These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 12971393)

  • 1. International Melanoma Research Congress--Foundation for Melanoma Research. 21-24 June 2003, Philadelphia, PA, USA.
    Swart GW
    IDrugs; 2003 Aug; 6(8):752-4. PubMed ID: 12971393
    [No Abstract]   [Full Text] [Related]  

  • 2. Melanoma Genomics and Immunotherapy.
    Constantinou M
    R I Med J (2013); 2015 Nov; 98(11):31-4. PubMed ID: 26517253
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trial watch: ipilimumab success in melanoma provides boost for cancer immunotherapy.
    Nat Rev Drug Discov; 2010 Aug; 9(8):584. PubMed ID: 20671754
    [No Abstract]   [Full Text] [Related]  

  • 4. Malignant melanoma.
    Schwartsmann G; Parkinson DR
    Cancer Chemother Biol Response Modif; 1994; 15():606-19. PubMed ID: 7779602
    [No Abstract]   [Full Text] [Related]  

  • 5. Systemic therapy for previously untreated advanced BRAF-mutated melanoma: navigating a shifting landscape.
    Levine O; Devji T; Xie F
    Immunotherapy; 2017 Mar; 9(5):375-378. PubMed ID: 28357918
    [No Abstract]   [Full Text] [Related]  

  • 6. Immunotherapy and Oncogenic Pathways: The PTEN Connection.
    Rizvi NA; Chan TA
    Cancer Discov; 2016 Feb; 6(2):128-9. PubMed ID: 26851183
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Meeting report from the 10th International Congress of the Society for Melanoma Research, Philadelphia, PA, November 2013.
    Vultur A; O'Connell M; Webster M; Villanueva J; Herlyn D; Somasundaram R; Krepler C; Zaidi R; Patton E; Sekulic A; Jonsson G; Weeraratna AT
    Pigment Cell Melanoma Res; 2014 Jul; 27(4):E1-E12. PubMed ID: 24650043
    [No Abstract]   [Full Text] [Related]  

  • 8. Newer developments in the immunotherapy of malignant melanoma.
    Maslin B; Alexandrescu DT; Ichim TE; Dasanu CA
    J Oncol Pharm Pract; 2014 Feb; 20(1):3-10. PubMed ID: 23435643
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Medical therapy of malignant melanoma].
    Mini E; Periti P
    Ann Ital Chir; 1989; 60(4):257-63. PubMed ID: 2699710
    [No Abstract]   [Full Text] [Related]  

  • 10. Melanoma drug wins US approval.
    Ledford H
    Nature; 2011 Mar; 471(7340):561. PubMed ID: 21455150
    [No Abstract]   [Full Text] [Related]  

  • 11. [Immunotherapies and melanoma].
    Routier É; Robert C; Mateus C
    Bull Cancer; 2014 Dec; 101 Suppl 2():S13-24. PubMed ID: 25776763
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Surveillance of the eye and vision in clinical trials of CP-675,206 for metastatic melanoma.
    Straatsma BR; Nusinowitz S; Young TA; Gordon LK; Chun MW; Rosen C; Seja E; Economou JS; Glaspy JA; Bozon V; Gomez-Navarro J; Ribas A
    Am J Ophthalmol; 2007 Jun; 143(6):958-969. PubMed ID: 17434437
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Update on immunotherapy in melanoma.
    Green J; Ariyan C
    Surg Oncol Clin N Am; 2015 Apr; 24(2):337-46. PubMed ID: 25769716
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunotherapy of malignant melanoma.
    Oratz R; Bystryn JC
    Dermatol Clin; 1991 Oct; 9(4):669-82. PubMed ID: 1718648
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New drugs in melanoma: it's a whole new world.
    Eggermont AM; Robert C
    Eur J Cancer; 2011 Sep; 47(14):2150-7. PubMed ID: 21802280
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Noninterferon-based adjuvant therapy for high-risk melanoma.
    Spitler LE
    Expert Rev Anticancer Ther; 2002 Oct; 2(5):547-62. PubMed ID: 12382523
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular and epigenetic features of melanomas and tumor immune microenvironment linked to durable remission to ipilimumab-based immunotherapy in metastatic patients.
    Seremet T; Koch A; Jansen Y; Schreuer M; Wilgenhof S; Del Marmol V; Liènard D; Thielemans K; Schats K; Kockx M; Van Criekinge W; Coulie PG; De Meyer T; van Baren N; Neyns B
    J Transl Med; 2016 Aug; 14(1):232. PubMed ID: 27484791
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Anti-CTLA-4 monoclonal antibody: a major step in the treatment of metastatic melanoma].
    Robert C; Mateus C
    Med Sci (Paris); 2011 Oct; 27(10):850-8. PubMed ID: 22027422
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Melanoma and immunotherapy.
    Eggermont AM; Schadendorf D
    Hematol Oncol Clin North Am; 2009 Jun; 23(3):547-64, ix-x. PubMed ID: 19464602
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Response of metastatic mucosal melanoma to immunotherapy: It can get worse before it gets better.
    Atrash S; Makhoul I; Mizell JS; Hutchins L; Mahmoud F
    J Oncol Pharm Pract; 2017 Apr; 23(3):215-219. PubMed ID: 26811403
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.